比較化学プロテオミクスによって特定された高度に選択的,可逆性阻害剤は,神経細胞におけるディアシルグリセロールリパース活性を調節する
Marc P Baggelaar1, Pascal J P Chameau2, Vasudev Kantae3
1†Department of Bioorganic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden 2300 RA, The Netherlands.
Journal of the American Chemical Society
|June 18, 2015
まとめ
研究者らは,ダイアシルグリセロールリパゼ (DAGL) -αおよび -β酵素に対する新しい選択性阻害剤,LEI105を開発しました. この発見は,エンドカンナビノイドシグナル伝達の研究を助け,2-AGの証拠を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 神経科学は神経科学である.
- 薬理学 薬理学とは
背景:
- ディアシルグリセロールリパゼ (DAGL) -αと-βは,重要なエンドカンナビノイドである2-アラキドノイルグリセロール (2-AG) を合成する重要な酵素です.
- 選択的および可逆的阻害剤は,神経細胞におけるDAGL機能を調査するために必要です.
- 現在の阻害剤は,急性研究に必要な選択性と時間制御が欠けている.
研究 の 目的:
- DAGL-αとDAGL-βの高度選択的阻害剤を特定し,特徴づけること.
- 阻害剤発見と選択性プロファイリングのための構造誘導設計とキモプロテオミクスを活用する.
- DAGLの阻害による逆行シグナル伝達における2-AGの役割を調査する.
主な方法:
- 比較的および競争的活動ベースのタンパク質プロファイリング (ABPP) を組み合わせたキモプロテオミクス戦略を採用しました.
- ブロードスペクトルフッロフォスフォナートと特定のβ-ラクトンプローブを使用して,複雑なタンパク質の阻害物質を特定しました.
- 他のエンドカンナビノイド代謝酵素およびカンナビノイド受容体に対する有効な阻害剤選択性.
主要な成果:
- α-ケトヘテロサイクルのLEI105が,強力で,選択的で,可逆性のダブルDAGL-α/DAGL-β阻害体として発見されました.
- LEI105は,関連する酵素 (ABHD6,ABHD12,MAGL,FAAH) の抑制や,CB1受容体に対する親和性を示しませんでした.
- LEI105は,Neuro2A細胞における2 - AGのレベルを低下させ,マウスのヒポキャンパスのスライスにおけるCB1受容体媒介のシナプス可塑性を抑制しました.
結論:
- LEI105は,DAGL機能とエンドカンナビノイドシグナル伝達の研究に役立つ貴重な薬理学的ツールです.
- この発見は,逆行シグナル伝達における"オンデマンド"の2-AG生物合成の仮説を裏付けている.
- この研究は,ネイティブの生物システム内の選択性酵素阻害剤を発見するABPPの力を強調しています.
関連する概念動画
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.9K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
3.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K
Enzyme Inhibition
95.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.2K
Feedback Inhibition
58.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
58.8K
IP3/DAG Signaling Pathway
16.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.0K


